Project
averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for KLF14_SP8
Z-value: 1.44
Motif logo
Transcription factors associated with KLF14_SP8
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
KLF14
|
ENSG00000174595.4 | Kruppel like factor 14 |
|
SP8
|
ENSG00000164651.12 | Sp8 transcription factor |
Activity profile of KLF14_SP8 motif
Sorted Z-values of KLF14_SP8 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of KLF14_SP8
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.6 | 30.4 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 4.7 | 14.0 | GO:1902365 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 3.8 | 11.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 3.3 | 3.3 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 3.0 | 3.0 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 3.0 | 9.0 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 2.8 | 11.2 | GO:0009386 | translational attenuation(GO:0009386) |
| 2.8 | 14.0 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 2.8 | 8.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 2.7 | 8.2 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 2.7 | 13.7 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 2.7 | 8.2 | GO:1903384 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 2.5 | 25.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 2.4 | 7.3 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 2.2 | 15.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 2.1 | 8.5 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 2.1 | 35.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 2.1 | 12.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 2.1 | 2.1 | GO:0035900 | response to isolation stress(GO:0035900) |
| 2.0 | 8.1 | GO:0090299 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 2.0 | 10.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 2.0 | 2.0 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 2.0 | 8.0 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 2.0 | 5.9 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 2.0 | 7.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 1.9 | 9.6 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 1.9 | 5.7 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 1.9 | 1.9 | GO:0001743 | optic placode formation(GO:0001743) |
| 1.9 | 22.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 1.9 | 5.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.8 | 1.8 | GO:0071506 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) |
| 1.8 | 7.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 1.8 | 25.3 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 1.7 | 17.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 1.7 | 3.5 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 1.7 | 5.2 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 1.7 | 5.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 1.7 | 5.1 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 1.7 | 6.7 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 1.7 | 6.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 1.7 | 6.7 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 1.7 | 30.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 1.6 | 6.5 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 1.6 | 4.9 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 1.6 | 8.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 1.6 | 4.8 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 1.6 | 1.6 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 1.6 | 4.7 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 1.5 | 6.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 1.5 | 4.5 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 1.5 | 3.0 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 1.5 | 5.9 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 1.4 | 4.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.4 | 2.9 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 1.4 | 9.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 1.4 | 4.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 1.3 | 8.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 1.3 | 2.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 1.3 | 5.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 1.3 | 2.6 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 1.3 | 10.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 1.3 | 29.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 1.3 | 5.0 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.2 | 4.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 1.2 | 3.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.2 | 3.6 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 1.2 | 3.6 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 1.2 | 9.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 1.2 | 4.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 1.1 | 6.9 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 1.1 | 11.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 1.1 | 4.5 | GO:0000023 | maltose metabolic process(GO:0000023) diaphragm contraction(GO:0002086) |
| 1.1 | 4.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 1.1 | 3.4 | GO:0051595 | response to methylglyoxal(GO:0051595) |
| 1.1 | 3.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 1.1 | 3.3 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.1 | 11.1 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 1.1 | 3.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 1.1 | 4.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 1.1 | 3.2 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 1.1 | 3.2 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.1 | 3.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 1.0 | 4.2 | GO:0021997 | neural plate axis specification(GO:0021997) centriole elongation(GO:0061511) |
| 1.0 | 1.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 1.0 | 5.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 1.0 | 5.1 | GO:1902075 | cellular response to salt(GO:1902075) |
| 1.0 | 3.0 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 1.0 | 3.9 | GO:0090625 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
| 1.0 | 1.9 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 1.0 | 2.9 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 1.0 | 1.9 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
| 0.9 | 5.7 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.9 | 10.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.9 | 4.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.9 | 5.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.9 | 3.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.9 | 4.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) histone H2A phosphorylation(GO:1990164) |
| 0.9 | 19.6 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.9 | 6.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.9 | 5.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.9 | 10.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.9 | 5.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.9 | 10.4 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.9 | 3.5 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.9 | 6.1 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.9 | 4.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.9 | 2.6 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.9 | 4.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.8 | 2.5 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.8 | 9.3 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.8 | 3.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.8 | 2.5 | GO:0032648 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
| 0.8 | 6.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.8 | 6.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.8 | 9.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.8 | 8.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.8 | 7.0 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.8 | 3.8 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.8 | 3.8 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.8 | 3.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.8 | 2.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.7 | 3.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.7 | 2.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.7 | 1.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.7 | 2.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.7 | 2.9 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.7 | 1.4 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
| 0.7 | 2.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.7 | 47.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.7 | 5.6 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
| 0.7 | 2.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.7 | 5.5 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.7 | 6.8 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.7 | 2.0 | GO:0048857 | neural nucleus development(GO:0048857) |
| 0.7 | 12.1 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.7 | 2.7 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.7 | 3.3 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.7 | 2.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.7 | 2.6 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.7 | 5.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.6 | 2.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.6 | 2.6 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.6 | 1.9 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.6 | 1.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.6 | 4.4 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.6 | 1.9 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.6 | 3.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.6 | 6.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.6 | 2.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.6 | 3.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.6 | 1.2 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.6 | 3.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.6 | 1.2 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
| 0.6 | 1.8 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.6 | 1.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.6 | 1.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.6 | 3.0 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 0.6 | 2.9 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.6 | 0.6 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 0.6 | 1.1 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.6 | 2.8 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.6 | 2.2 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.6 | 2.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.5 | 8.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.5 | 4.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.5 | 3.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.5 | 2.2 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.5 | 2.2 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.5 | 1.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.5 | 3.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.5 | 4.8 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.5 | 3.7 | GO:0045007 | depurination(GO:0045007) |
| 0.5 | 2.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.5 | 3.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.5 | 5.2 | GO:0015791 | polyol transport(GO:0015791) |
| 0.5 | 10.8 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.5 | 2.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.5 | 9.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.5 | 1.5 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.5 | 1.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.5 | 9.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.5 | 2.5 | GO:0003431 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) Harderian gland development(GO:0070384) |
| 0.5 | 3.5 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.5 | 1.0 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.5 | 2.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.5 | 2.0 | GO:0061743 | motor learning(GO:0061743) |
| 0.5 | 1.0 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.5 | 3.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.5 | 3.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.5 | 4.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.5 | 0.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.5 | 1.5 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.5 | 1.0 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.5 | 1.0 | GO:1903059 | positive regulation of lipoprotein metabolic process(GO:0050747) regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.5 | 3.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.5 | 5.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.5 | 0.9 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.5 | 1.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 0.5 | 1.9 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.5 | 2.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.5 | 2.7 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.5 | 4.6 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.5 | 1.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.5 | 1.8 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.5 | 6.3 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.5 | 4.5 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.4 | 2.2 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 0.4 | 2.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.4 | 1.8 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.4 | 1.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.4 | 1.3 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.4 | 0.9 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.4 | 0.4 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.4 | 2.2 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.4 | 1.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.4 | 1.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.4 | 1.3 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.4 | 2.1 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.4 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.4 | 1.7 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.4 | 4.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.4 | 1.2 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.4 | 2.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.4 | 1.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.4 | 1.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.4 | 0.8 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.4 | 0.8 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 0.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.4 | 7.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.4 | 7.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.4 | 4.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.4 | 0.8 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.4 | 1.2 | GO:0035054 | septum secundum development(GO:0003285) embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.4 | 0.8 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.4 | 10.5 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 0.4 | 1.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.4 | 3.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.4 | 2.7 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.4 | 3.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.4 | 1.1 | GO:0009080 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.4 | 1.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.4 | 0.7 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 0.4 | 1.8 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.4 | 0.7 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.4 | 8.5 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.4 | 1.1 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.4 | 2.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.4 | 2.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.4 | 1.5 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.4 | 1.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.4 | 3.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.4 | 2.9 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.4 | 2.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.4 | 4.3 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.4 | 1.1 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.4 | 3.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.4 | 8.5 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.4 | 3.2 | GO:0015871 | choline transport(GO:0015871) |
| 0.4 | 2.5 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.3 | 1.0 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.3 | 7.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 0.3 | 1.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.3 | 3.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.3 | 1.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 0.3 | 1.0 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.3 | 1.4 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.3 | 1.7 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.3 | 0.7 | GO:0015942 | formate metabolic process(GO:0015942) histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.3 | 4.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.3 | 8.7 | GO:0048515 | spermatid development(GO:0007286) spermatid differentiation(GO:0048515) |
| 0.3 | 1.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.3 | 1.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 | 3.6 | GO:0048243 | norepinephrine secretion(GO:0048243) |
| 0.3 | 0.7 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
| 0.3 | 1.0 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.3 | 1.6 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.3 | 1.0 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.3 | 1.6 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.3 | 4.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.3 | 1.6 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.3 | 6.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
| 0.3 | 1.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.3 | 4.7 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.3 | 4.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.3 | 1.8 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.3 | 4.6 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
| 0.3 | 2.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.3 | 1.5 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.3 | 2.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.3 | 2.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.3 | 6.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.3 | 3.9 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.3 | 3.9 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.3 | 2.4 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.3 | 0.9 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 0.3 | 8.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.3 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.3 | 1.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.3 | 5.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.3 | 0.9 | GO:0070781 | response to biotin(GO:0070781) |
| 0.3 | 20.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.3 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 | 0.9 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.3 | 1.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 | 0.9 | GO:0021781 | glial cell fate commitment(GO:0021781) |
| 0.3 | 11.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.3 | 3.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.3 | 2.0 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
| 0.3 | 1.1 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.3 | 1.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.3 | 0.6 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.3 | 0.6 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.3 | 4.7 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 | 2.2 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.3 | 1.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.3 | 2.5 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.3 | 4.6 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.3 | 0.8 | GO:0060529 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) mammary gland specification(GO:0060594) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.3 | 2.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.3 | 5.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.3 | 4.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.3 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 | 10.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.3 | 0.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.3 | 2.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.3 | 3.8 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.3 | 0.8 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.3 | 1.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 | 4.8 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.2 | 3.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 | 4.4 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.2 | 4.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.2 | 1.2 | GO:0060612 | adipose tissue development(GO:0060612) |
| 0.2 | 0.7 | GO:2000525 | dendritic cell dendrite assembly(GO:0097026) regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.2 | 0.7 | GO:0051231 | spindle elongation(GO:0051231) |
| 0.2 | 5.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.2 | 1.9 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.2 | 1.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 | 4.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.2 | 3.4 | GO:0006273 | lagging strand elongation(GO:0006273) |
| 0.2 | 2.9 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 2.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 | 2.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
| 0.2 | 0.7 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.2 | 11.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.2 | 4.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.2 | 2.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 | 5.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.2 | 4.0 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.2 | 1.6 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.2 | 0.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 0.2 | 7.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.2 | 0.9 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.2 | 1.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 | 0.7 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) B cell selection(GO:0002339) |
| 0.2 | 0.9 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.2 | 7.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.2 | 0.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.2 | 1.4 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.2 | 2.9 | GO:0070977 | bone maturation(GO:0070977) |
| 0.2 | 12.6 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 0.7 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 | 3.3 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.2 | 1.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 5.7 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.2 | 2.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.2 | 2.0 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.2 | 0.4 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.2 | 1.1 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 0.2 | 6.3 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.2 | 0.7 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.2 | 0.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 0.2 | 2.4 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.2 | 0.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.2 | 0.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.2 | 0.6 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.2 | 2.3 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.2 | 1.9 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 | 5.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.2 | 2.9 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.2 | 2.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.2 | 1.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.2 | 4.0 | GO:0042026 | protein refolding(GO:0042026) |
| 0.2 | 4.0 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.2 | 1.6 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.2 | 1.0 | GO:1903818 | globus pallidus development(GO:0021759) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 | 1.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.2 | 3.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 | 0.6 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.2 | 2.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 1.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.2 | 3.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.2 | 2.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.2 | 4.3 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.2 | 3.0 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.2 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.2 | 2.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.2 | 13.1 | GO:0046323 | glucose import(GO:0046323) |
| 0.2 | 0.2 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.2 | 1.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.2 | 1.5 | GO:0009304 | transcription initiation from RNA polymerase III promoter(GO:0006384) tRNA transcription(GO:0009304) |
| 0.2 | 0.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 1.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.2 | 0.9 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 1.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 | 0.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.2 | 2.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.2 | 0.2 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 0.2 | 2.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 | 1.2 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 0.9 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.2 | 2.4 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.2 | 1.7 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.2 | 1.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.2 | 1.0 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.2 | 0.8 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 0.7 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.2 | 3.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.2 | 1.5 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.2 | 2.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.2 | 1.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 | 2.6 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.2 | 2.9 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.2 | 3.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.2 | 0.3 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 0.2 | 0.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.2 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 | 48.6 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
| 0.2 | 2.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.2 | 1.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.2 | 2.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.2 | 0.2 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.2 | 1.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.2 | 1.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 1.0 | GO:0006818 | hydrogen transport(GO:0006818) proton transport(GO:0015992) |
| 0.1 | 0.3 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
| 0.1 | 0.6 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.1 | 1.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 3.2 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.1 | 4.5 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.1 | 2.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 2.3 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
| 0.1 | 1.4 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.1 | 1.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 | 2.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.4 | GO:0021938 | ventral midline development(GO:0007418) cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.1 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 | 2.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 | 0.4 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.1 | 2.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.1 | 1.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.1 | 1.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 3.3 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 1.3 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.1 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 | 1.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 7.9 | GO:0007602 | phototransduction(GO:0007602) |
| 0.1 | 1.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.1 | 0.6 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.1 | 2.2 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.1 | 5.5 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.1 | 0.6 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 | 0.6 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
| 0.1 | 1.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 0.1 | 1.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 3.5 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.1 | 0.4 | GO:0014075 | response to amine(GO:0014075) |
| 0.1 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 | 3.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 0.6 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.1 | 1.5 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.2 | GO:0097477 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.1 | 2.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.1 | 0.5 | GO:0035701 | striatal medium spiny neuron differentiation(GO:0021773) hematopoietic stem cell migration(GO:0035701) |
| 0.1 | 1.9 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 0.1 | 1.5 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.1 | 0.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 | 2.9 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.1 | 0.6 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.1 | 2.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.1 | 0.9 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 0.8 | GO:0038111 | interleukin-7-mediated signaling pathway(GO:0038111) |
| 0.1 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 | 1.9 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 | 1.6 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 2.7 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
| 0.1 | 2.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 0.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 1.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 | 0.5 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.1 | 0.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.1 | 2.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
| 0.1 | 0.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 0.7 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.1 | 1.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.1 | 0.5 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.1 | 1.8 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.1 | 0.7 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
| 0.1 | 1.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 0.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 | 1.8 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 | 0.5 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) |
| 0.1 | 0.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.1 | 3.3 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.1 | 0.6 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.1 | 4.7 | GO:0008344 | adult locomotory behavior(GO:0008344) |
| 0.1 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.1 | 0.2 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.1 | 5.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.3 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 1.6 | GO:0061512 | protein localization to cilium(GO:0061512) |
| 0.1 | 7.2 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.1 | 2.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.1 | 5.4 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 1.8 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 0.2 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.1 | 1.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.1 | 0.5 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
| 0.1 | 0.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
| 0.1 | 0.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 | 0.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
| 0.1 | 0.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.1 | 1.5 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.1 | 0.9 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.4 | GO:0023058 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
| 0.1 | 2.5 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
| 0.1 | 0.7 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.1 | 4.4 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 | 1.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 1.2 | GO:0000187 | activation of MAPK activity(GO:0000187) |
| 0.1 | 1.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.1 | 1.2 | GO:0048536 | spleen development(GO:0048536) |
| 0.1 | 0.8 | GO:0009636 | response to toxic substance(GO:0009636) |
| 0.1 | 1.1 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.1 | 2.9 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 | 1.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.1 | 0.9 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 1.4 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.1 | 0.1 | GO:1902931 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) negative regulation of alcohol biosynthetic process(GO:1902931) |
| 0.1 | 1.0 | GO:0016236 | macroautophagy(GO:0016236) |
| 0.1 | 1.4 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
| 0.1 | 3.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 0.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.1 | 1.8 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.1 | 0.2 | GO:1901621 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 1.4 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.1 | 0.6 | GO:0021510 | spinal cord development(GO:0021510) |
| 0.1 | 1.1 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.1 | 0.5 | GO:0036066 | negative regulation of chondrocyte differentiation(GO:0032331) protein O-linked fucosylation(GO:0036066) negative regulation of cartilage development(GO:0061037) |
| 0.1 | 0.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.5 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 3.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.0 | 0.1 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.0 | 1.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.9 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.0 | 1.3 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 0.3 | GO:0009415 | response to water(GO:0009415) |
| 0.0 | 0.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 0.0 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.0 | 0.3 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 0.4 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.0 | 1.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.8 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.0 | 0.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) sensory perception of temperature stimulus(GO:0050951) |
| 0.0 | 0.3 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.0 | 0.5 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.0 | 0.5 | GO:0032196 | transposition(GO:0032196) |
| 0.0 | 0.4 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
| 0.0 | 0.4 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 0.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 | 0.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.0 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.0 | 0.1 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.0 | 0.3 | GO:0006914 | autophagy(GO:0006914) |
| 0.0 | 0.2 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
| 0.0 | 0.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.0 | 0.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.0 | 1.1 | GO:0021954 | central nervous system neuron development(GO:0021954) |
| 0.0 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 1.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 2.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 | 0.6 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.0 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.0 | 0.7 | GO:0003170 | heart valve development(GO:0003170) |
| 0.0 | 0.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.0 | 0.6 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
| 0.0 | 0.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.0 | 1.4 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
| 0.0 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 | 0.4 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.0 | 0.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 0.0 | 0.3 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
| 0.0 | 0.7 | GO:0009880 | embryonic pattern specification(GO:0009880) |
| 0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 2.8 | GO:0030449 | regulation of complement activation(GO:0030449) |
| 0.0 | 1.5 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.0 | 0.4 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.0 | 0.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.0 | 0.3 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 | 0.2 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.0 | 0.3 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 | 0.2 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.0 | 0.7 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.0 | 0.1 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.0 | 0.8 | GO:0001510 | RNA methylation(GO:0001510) |
| 0.0 | 0.3 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.2 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
| 0.0 | 0.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 | 1.7 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
| 0.0 | 0.7 | GO:0007626 | locomotory behavior(GO:0007626) |
| 0.0 | 0.0 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.0 | 0.2 | GO:0097435 | fibril organization(GO:0097435) |
| 0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
| 0.0 | 0.5 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
| 0.0 | 0.0 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 0.3 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.0 | 0.2 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.0 | 0.2 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.3 | 29.3 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 4.7 | 14.0 | GO:0061673 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
| 4.2 | 25.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 3.6 | 14.4 | GO:0070695 | FHF complex(GO:0070695) |
| 2.8 | 11.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 2.4 | 7.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 2.4 | 7.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 2.2 | 26.8 | GO:0044327 | dendritic spine head(GO:0044327) |
| 2.1 | 10.4 | GO:0033263 | CORVET complex(GO:0033263) |
| 2.1 | 14.5 | GO:0001520 | outer dense fiber(GO:0001520) |
| 1.9 | 11.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.6 | 13.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 1.6 | 12.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 1.6 | 20.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 1.5 | 10.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 1.4 | 14.0 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 1.4 | 4.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 1.3 | 1.3 | GO:0000145 | exocyst(GO:0000145) |
| 1.3 | 2.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 1.3 | 5.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 1.2 | 9.7 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 1.1 | 7.4 | GO:0097427 | microtubule bundle(GO:0097427) |
| 1.0 | 5.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.9 | 9.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.9 | 2.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.9 | 11.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.8 | 2.5 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.8 | 5.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.8 | 8.0 | GO:0097413 | Lewy body(GO:0097413) |
| 0.8 | 2.4 | GO:0000806 | Y chromosome(GO:0000806) |
| 0.7 | 4.5 | GO:0002177 | manchette(GO:0002177) |
| 0.7 | 8.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.7 | 10.0 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.7 | 2.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.7 | 2.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.7 | 1.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.7 | 20.7 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.7 | 5.5 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.7 | 3.4 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.7 | 2.7 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.7 | 2.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.7 | 18.0 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.6 | 2.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.6 | 9.5 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.6 | 5.6 | GO:0000800 | lateral element(GO:0000800) |
| 0.6 | 6.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.6 | 6.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.6 | 7.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.6 | 2.4 | GO:1990745 | EARP complex(GO:1990745) |
| 0.6 | 1.8 | GO:0098536 | deuterosome(GO:0098536) |
| 0.6 | 1.8 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.6 | 4.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.6 | 2.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.6 | 2.8 | GO:1990393 | 3M complex(GO:1990393) |
| 0.6 | 3.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.5 | 3.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.5 | 3.8 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.5 | 2.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.5 | 4.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.5 | 5.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.4 | 4.4 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
| 0.4 | 1.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.4 | 1.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.4 | 4.7 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.4 | 1.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.4 | 2.5 | GO:0051286 | cell tip(GO:0051286) |
| 0.4 | 22.0 | GO:0016235 | aggresome(GO:0016235) |
| 0.4 | 2.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.4 | 1.5 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.4 | 0.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.4 | 1.9 | GO:0060091 | kinocilium(GO:0060091) |
| 0.4 | 8.9 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.4 | 4.4 | GO:0035859 | Seh1-associated complex(GO:0035859) |
| 0.4 | 12.1 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.4 | 13.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.4 | 2.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.4 | 1.4 | GO:0031417 | NatC complex(GO:0031417) |
| 0.3 | 1.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.3 | 8.7 | GO:0097546 | ciliary base(GO:0097546) |
| 0.3 | 13.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.3 | 2.4 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.3 | 3.0 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.3 | 14.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.3 | 5.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.3 | 3.5 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.3 | 3.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.3 | 0.9 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.3 | 20.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.3 | 20.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.3 | 5.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.3 | 0.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.3 | 3.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.3 | 3.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.3 | 0.8 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.3 | 3.0 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.2 | 6.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.2 | 5.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.2 | 1.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.2 | 2.4 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.2 | 2.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.2 | 8.3 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.2 | 16.6 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.2 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.2 | 3.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.2 | 2.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 1.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.2 | 5.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.2 | 2.2 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.2 | 2.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 1.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.2 | 0.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.2 | 14.6 | GO:0005814 | centriole(GO:0005814) |
| 0.2 | 21.6 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.2 | 1.4 | GO:0072487 | MSL complex(GO:0072487) |
| 0.2 | 3.8 | GO:0044450 | microtubule organizing center part(GO:0044450) |
| 0.2 | 15.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.2 | 1.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.2 | 1.7 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 2.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.2 | 1.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.2 | 1.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.2 | 1.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.2 | 9.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.2 | 1.4 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.2 | 0.9 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.2 | 1.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 10.3 | GO:0031514 | motile cilium(GO:0031514) |
| 0.2 | 1.3 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.2 | 0.7 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.2 | 13.6 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.2 | 0.8 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 1.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.2 | 2.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.2 | 2.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.1 | 1.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 11.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 1.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 1.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 0.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.1 | 3.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.1 | 12.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 2.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.1 | 1.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 16.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.1 | 1.3 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 3.8 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 0.4 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.1 | 1.5 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 0.8 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.1 | 2.2 | GO:0042627 | chylomicron(GO:0042627) |
| 0.1 | 25.9 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.1 | 4.9 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 1.1 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 0.6 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 1.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 11.0 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 3.8 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.1 | 1.2 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.1 | 8.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 1.6 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 0.9 | GO:0008021 | synaptic vesicle(GO:0008021) exocytic vesicle(GO:0070382) |
| 0.1 | 6.6 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 1.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.1 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.1 | 0.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.1 | 1.2 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 0.5 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.1 | 5.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 0.4 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.1 | 13.0 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 1.9 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 2.3 | GO:0030175 | filopodium(GO:0030175) |
| 0.1 | 2.2 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 6.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.1 | 7.4 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 0.9 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.1 | 0.5 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.1 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 11.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 4.7 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 2.3 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 0.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.1 | 0.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.1 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 2.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 28.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
| 0.1 | 0.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 0.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.1 | 2.6 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 1.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 1.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.6 | GO:0031672 | A band(GO:0031672) |
| 0.0 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.0 | 3.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.0 | 1.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.0 | 4.7 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 1.7 | GO:0098794 | postsynapse(GO:0098794) |
| 0.0 | 1.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.0 | 0.8 | GO:0043235 | receptor complex(GO:0043235) |
| 0.0 | 0.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.0 | 2.4 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.0 | 0.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 0.2 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.1 | GO:0045180 | basal cortex(GO:0045180) |
| 0.0 | 1.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 1.6 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 1.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.0 | 0.2 | GO:0070069 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) cytochrome complex(GO:0070069) |
| 0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.0 | 0.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.0 | 0.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 0.1 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.0 | 1.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.5 | 38.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 3.0 | 12.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 2.9 | 14.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 2.8 | 8.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 2.7 | 16.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 2.4 | 29.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 2.4 | 7.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 2.3 | 14.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 2.1 | 10.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 2.1 | 10.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 2.1 | 10.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 2.0 | 10.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 2.0 | 8.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 2.0 | 5.9 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 1.9 | 7.6 | GO:0017040 | ceramidase activity(GO:0017040) |
| 1.9 | 5.7 | GO:0032093 | SAM domain binding(GO:0032093) |
| 1.8 | 25.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 1.8 | 7.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 1.7 | 12.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 1.7 | 14.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 1.6 | 15.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 1.5 | 4.5 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 1.5 | 4.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 1.5 | 4.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 1.4 | 8.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 1.4 | 11.2 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 1.4 | 10.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 1.4 | 5.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 1.3 | 8.1 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 1.3 | 5.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 1.3 | 3.9 | GO:0015039 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 1.2 | 4.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 1.2 | 29.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 1.2 | 3.5 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 1.1 | 3.3 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 1.1 | 9.8 | GO:0000182 | rDNA binding(GO:0000182) |
| 1.1 | 14.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 1.1 | 3.2 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 1.1 | 2.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 1.0 | 3.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 1.0 | 4.1 | GO:0035939 | microsatellite binding(GO:0035939) |
| 1.0 | 3.0 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 1.0 | 5.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 1.0 | 3.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 1.0 | 2.9 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 1.0 | 21.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 1.0 | 4.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.9 | 17.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.9 | 6.4 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.9 | 3.7 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.9 | 4.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.9 | 2.7 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.9 | 7.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.9 | 5.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.8 | 3.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.8 | 2.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.8 | 5.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.8 | 14.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.8 | 3.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.8 | 4.7 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.8 | 3.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.8 | 13.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.8 | 7.6 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.8 | 3.0 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.7 | 3.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.7 | 1.5 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 0.7 | 2.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.7 | 12.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.7 | 12.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.7 | 4.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.7 | 15.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.7 | 2.0 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.7 | 3.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.6 | 5.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.6 | 3.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.6 | 4.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.6 | 4.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.6 | 8.6 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.6 | 4.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.6 | 0.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.6 | 3.0 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.6 | 4.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.6 | 2.8 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.6 | 2.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.6 | 1.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.6 | 5.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.5 | 15.5 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.5 | 3.2 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.5 | 2.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.5 | 1.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 0.5 | 13.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.5 | 1.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.5 | 4.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.5 | 1.0 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.5 | 1.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.5 | 16.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.5 | 1.9 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.5 | 3.3 | GO:0043559 | insulin binding(GO:0043559) |
| 0.5 | 2.3 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.4 | 3.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.4 | 1.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.4 | 33.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.4 | 5.3 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.4 | 3.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.4 | 2.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.4 | 5.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.4 | 6.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.4 | 1.3 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.4 | 2.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.4 | 3.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.4 | 4.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.4 | 1.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.4 | 9.0 | GO:0005521 | lamin binding(GO:0005521) |
| 0.4 | 1.2 | GO:0035473 | lipase binding(GO:0035473) |
| 0.4 | 4.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.4 | 2.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.4 | 23.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
| 0.4 | 1.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.4 | 5.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.4 | 4.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.4 | 6.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.4 | 1.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.4 | 9.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.4 | 1.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.4 | 5.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.4 | 3.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.4 | 4.8 | GO:0043495 | protein anchor(GO:0043495) |
| 0.4 | 5.2 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.4 | 1.5 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.4 | 1.8 | GO:0070728 | leucine binding(GO:0070728) |
| 0.3 | 2.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.3 | 3.4 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.3 | 1.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.3 | 3.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.3 | 1.3 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.3 | 3.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.3 | 1.9 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.3 | 2.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.3 | 0.9 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.3 | 0.9 | GO:0015403 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.3 | 1.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.3 | 3.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.3 | 1.4 | GO:0005112 | Notch binding(GO:0005112) |
| 0.3 | 0.9 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.3 | 0.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.3 | 1.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.3 | 7.2 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.3 | 2.2 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.3 | 2.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.3 | 1.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.3 | 11.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.3 | 1.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.3 | 1.6 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.3 | 4.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.3 | 6.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.3 | 4.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.3 | 7.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.3 | 88.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 7.7 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.2 | 1.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.2 | 2.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.2 | 0.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.2 | 1.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.2 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 6.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 1.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.2 | 12.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 0.7 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.2 | 3.8 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 5.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.2 | 2.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 1.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 4.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.2 | 4.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.2 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.2 | 1.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.2 | 4.8 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
| 0.2 | 1.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.2 | 5.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 3.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 1.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.2 | 2.2 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.2 | 1.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 2.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.2 | 1.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.2 | 1.0 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.2 | 2.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.2 | 0.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.2 | 1.8 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
| 0.2 | 1.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 2.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.2 | 0.7 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.2 | 2.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 0.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.2 | 1.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.2 | 0.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.2 | 2.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.2 | 1.3 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.2 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 0.6 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.2 | 0.3 | GO:0004803 | transposase activity(GO:0004803) |
| 0.2 | 4.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.2 | 2.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 2.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.2 | 1.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.2 | 4.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.2 | 0.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.2 | 0.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.2 | 3.0 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.1 | 1.9 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 2.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 16.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.1 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 2.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.1 | 1.4 | GO:0009374 | biotin binding(GO:0009374) |
| 0.1 | 4.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 0.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 1.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 1.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 2.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 4.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.1 | 3.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 5.1 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.1 | 1.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 1.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 0.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 0.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 40.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.1 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 4.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 6.7 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 1.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 1.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.1 | 4.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 1.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.1 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.1 | 0.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.1 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 4.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.1 | 4.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.1 | 0.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 0.6 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 7.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.1 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 1.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 1.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.1 | 5.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 0.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.1 | 2.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.1 | 1.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.1 | 1.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.1 | 2.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
| 0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 0.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.1 | 1.5 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.1 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.1 | 0.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.1 | 0.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
| 0.1 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 4.6 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.1 | 0.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
| 0.1 | 2.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 0.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 1.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 1.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 1.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 4.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 1.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.1 | 0.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.1 | 2.0 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 1.8 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.1 | 0.2 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.1 | 1.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 0.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.1 | 1.0 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.2 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 0.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.1 | 0.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.1 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.1 | 0.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 2.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 1.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.1 | 2.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 27.6 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
| 0.1 | 0.7 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 1.8 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 2.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 0.7 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 0.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.1 | 0.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 0.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.1 | 2.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 3.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 2.4 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
| 0.0 | 0.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.0 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.0 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.0 | 2.6 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 0.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 2.9 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.0 | 10.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.0 | 1.3 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.0 | 1.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.0 | 0.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.0 | 2.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 4.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 2.6 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.0 | 0.2 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
| 0.0 | 0.5 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.0 | 1.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.0 | 0.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.0 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.0 | 0.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
| 0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
| 0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 2.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.0 | 0.7 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
| 0.0 | 15.6 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 0.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.0 | 2.8 | GO:0019902 | phosphatase binding(GO:0019902) |
| 0.0 | 1.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.8 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 1.4 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.0 | 0.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.0 | 0.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.0 | 0.1 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 1.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 0.3 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.0 | 0.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.0 | 5.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 0.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.0 | 0.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 1.3 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
| 0.0 | 2.9 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
| 0.0 | 0.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.0 | 0.4 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.0 | 0.0 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 1.1 | GO:0005179 | hormone activity(GO:0005179) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 15.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.6 | 13.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.6 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.5 | 39.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.5 | 5.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.5 | 5.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.5 | 10.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.5 | 10.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.4 | 3.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.3 | 2.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.3 | 1.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.3 | 27.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.3 | 2.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.3 | 5.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.3 | 4.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.3 | 1.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 2.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 4.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.2 | 10.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 3.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.2 | 5.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.2 | 3.0 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.2 | 11.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.2 | 10.2 | PID FGF PATHWAY | FGF signaling pathway |
| 0.2 | 15.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.2 | 2.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.2 | 24.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.2 | 9.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.2 | 4.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.2 | 3.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.2 | 3.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.2 | 0.6 | PID EPO PATHWAY | EPO signaling pathway |
| 0.2 | 8.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.2 | 5.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 11.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 8.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 4.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 0.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 1.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 4.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 8.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 2.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 2.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 4.1 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 4.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 3.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 5.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.1 | 4.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 1.0 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.1 | 2.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 1.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 2.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 1.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 1.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 9.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 2.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 1.7 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 2.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 0.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 1.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 8.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 0.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 2.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 28.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.8 | 12.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.7 | 1.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.6 | 12.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.6 | 1.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.5 | 7.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.5 | 22.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.5 | 13.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.5 | 9.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.5 | 3.8 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.5 | 22.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.4 | 5.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.4 | 7.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.4 | 7.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.4 | 5.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.4 | 3.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.4 | 11.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.3 | 11.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.3 | 30.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.3 | 10.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.3 | 6.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.3 | 3.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.3 | 12.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.3 | 2.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.3 | 6.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.3 | 4.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.2 | 1.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.2 | 2.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.2 | 2.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.2 | 6.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 3.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.2 | 5.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.2 | 4.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.2 | 1.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.2 | 6.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.2 | 3.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.2 | 3.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.2 | 6.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.2 | 6.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 2.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 5.4 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.2 | 3.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.2 | 25.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.2 | 0.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.2 | 10.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.2 | 3.6 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
| 0.2 | 3.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 3.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 12.6 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.1 | 1.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 4.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 0.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 3.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.1 | 4.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 4.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 1.7 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
| 0.1 | 2.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 7.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 1.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.1 | 3.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 3.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 0.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 2.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 1.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 3.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.1 | 2.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 1.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 1.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 6.0 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.1 | 1.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 1.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 4.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.1 | 6.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 1.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 1.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 2.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.1 | 1.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 1.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 1.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 1.5 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.1 | 2.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.1 | 1.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 0.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.1 | 0.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 1.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 1.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 2.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 1.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.0 | 1.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 11.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 0.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 1.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 2.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 1.2 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
| 0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.0 | 0.8 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
| 0.0 | 0.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.0 | 0.8 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.0 | 1.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 1.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.0 | 0.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.0 | 0.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.0 | 1.3 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| 0.0 | 1.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.0 | 0.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 0.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |